Federal Health Agency Hosts Talk On Psychedelics Research
A federal health agency invited a noted psychedelics researcher to discuss the science of substances such as psilocybin mushrooms as part of an “innovation speaker series” it’s hosting next week. The National Institute of Mental Health (NIMH) announced that Roland Griffiths, who heads Johns Hopkins University’s newly launched Center for For Psychedelic Research, will lead a discussion titled “Psilocybin: History, Neuropharmacology, and Implications for Therapeutics” on December 3. The focus of Dr. Roland Griffiths’ research has been on the behavioral and subjective effects of mood-altering drugs—namely the psychedelic psilocybin. Tune in to learn more from our next @NIMHgov Director’s Innovation Speaker! https://t.co/4vddJamioQ pic.twitter.com/yunXelQlwt — Joshua A. Gordon (@NIMHDirector) November 26, 2019 “In this presentation, Dr. Griffiths will review the history, epidemiology, risks, and neuropharmacology of classic psychedelic drugs,” NIMH said. “The presentation will highlight research into the effects of psilocybin in healthy volunteers, in beginning and long-term meditators, and in religious leaders.” The federal agency, which operates under the National Institutes of Health (NIH), highlighted ongoing research into the therapeutic potential of psychedelics in the treatment of conditions such as major depression and helping people quit smoking. A recent scientific review published in the Journal of Psychiatric Practice supported such…
Excerpt only …
READ MORE BELOW
Source : MJ moment
Link to original : Federal Health Agency Hosts Talk On Psychedelics Research
reposted by Cannabis News World
You must log in to post a comment.